Since mutant IDH1/2 enzymes convert α-KG into 2-HG, cancer cells carrying these mutants should have alterations in the concentration of TCA cycle intermediates, and require substitution of energy sources to attenuate the deficiency of metabolic substrates. Here, IDH1 is linked to cancer.